Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Harm Reduction Intervention for Anabolic-androgenic Steroids Users: a Randomized Controlled Trial

NCT07039539 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT07039539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07039539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Harm Reduction Intervention for Anabolic-androgenic Steroids Users: a Randomized Controlled Trial
Lead sponsor
University of Sao Paulo
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
January 30, 2028
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anabolic steroids adverse events, brief intervention, drug abuse, harm reduction, minimization, harm